Clinical Trials Directory

Trials / Conditions / Advanced Prostate Carcinoma

Advanced Prostate Carcinoma

14 registered clinical trials studyying Advanced Prostate Carcinoma — 4 currently recruiting.

StatusTrialSponsorPhase
Active Not RecruitingA Precision Medicine Approach (SMMART-ACT) for the Treatment of Patients With Advanced Sarcoma, Prostate, Brea
NCT06630325
OHSU Knight Cancer InstitutePhase 2
RecruitingBright White Light Therapy in Reducing Cancer-Related Fatigue and Depression in Advanced Prostate Cancer Patie
NCT05869682
City of Hope Medical CenterPhase 2
RecruitingAt-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer
NCT05969860
Mayo ClinicPhase 2
WithdrawnSMMART Adaptive Clinical Treatment (ACT) Trial
NCT05238831
OHSU Knight Cancer InstituteEARLY_Phase 1
CompletedPhysical Function During ARSI Treatment
NCT05612880
UNC Lineberger Comprehensive Cancer Center—
RecruitingPatient Decision-making About Precision Oncology in Veterans With Advanced Prostate Cancer
NCT05396872
University of California, San FranciscoN/A
Active Not RecruitingTesting the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced
NCT04514484
National Cancer Institute (NCI)Phase 1
UnknownImproving Diagnosis and Treatment of Metastatic Advanced Prostate Cancer
NCT04984395
Royal Marsden NHS Foundation Trust—
Active Not RecruitingDarolutamide + Consolidation Radiotherapy in Advanced Prostate Cancer Detected by PSMA
NCT04319783
Trans Tasman Radiation Oncology GroupPhase 2
UnknownThe Wolverhampton Assessment Tool, a Tool for Patient-reported Wellbeing in the Context of Prostate Cancer
NCT04851639
University of WolverhamptonN/A
RecruitingMagnetic Resonance Imaging (MRI) With Hyperpolarized Pyruvate (13C) as Diagnostic Tool in Advanced Prostate Ca
NCT04346225
Ivan de Kouchkovsky, MDPhase 2
Active Not RecruitingPI3Kbeta Inhibitor AZD8186 and Docetaxel in Treating Patients Advanced Solid Tumors With PTEN or PIK3CB Mutati
NCT03218826
National Cancer Institute (NCI)Phase 1
UnknownProspective REgistry of Targeted RadionucLide TherapY in Patients With mCRPC (REALITY Study)
NCT04833517
Universität des Saarlandes—
CompletedAn Observational Study Looking at How Well the Drug Eligard Works and How Well it is Tolerated by the Body of
NCT02128334
Astellas Pharma Europe B.V.—